Cargando…

Adjuvant chemotherapy for early breast cancer.

Detalles Bibliográficos
Autor principal:	Henderson, I. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971592/ https://www.ncbi.nlm.nih.gov/pubmed/2186772

Ejemplares similares

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer
por: Goldrick, A., et al.
Publicado: (2007)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001)

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
por: Bianco, A. R., et al.
Publicado: (1991)

Psychoneuroimmunology-Based Stress Management during Adjuvant Chemotherapy for Early Breast Cancer
por: Robins, Jo Lynne W., et al.
Publicado: (2013)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

The impact of early adjuvant chemotherapy in rectal cancer
por: Noh, Gyoung Tae, et al.
Publicado: (2020)

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?
por: Alliot, C
Publicado: (2006)

Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy
por: Carmona-Bayonas, Alberto, et al.
Publicado: (2021)

Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
por: Esbah, Onur, et al.
Publicado: (2017)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients
por: Ishitobi, Makoto, et al.
Publicado: (2013)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Jiang, Bing, et al.
Publicado: (2021)

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
por: Jahn, B., et al.
Publicado: (2015)

Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)

Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer
por: Christensen, Carina Ørts, et al.
Publicado: (2016)

Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer
por: López-Tarruella, Sara, et al.
Publicado: (2009)

Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly
por: Sun, J, et al.
Publicado: (2017)

Is adjuvant chemotherapy necessary in older patients with breast cancer?
por: Morita, Midori, et al.
Publicado: (2022)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Perturbations of Adjuvant Chemotherapy on Cardiovascular Responses and Exercise Tolerance in Patients with Early-Stage Breast Cancer
por: Lin, Hsin-Fu, et al.
Publicado: (2021)

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
por: Licata, Luca, et al.
Publicado: (2023)

Dose-dense adjuvant chemotherapy for primary breast cancer
por: Fornier, Monica, et al.
Publicado: (2005)

Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer
por: Liu, Xiaozhen, et al.
Publicado: (2016)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

Association between weight gain during adjuvant chemotherapy for early‐stage breast cancer and survival outcomes
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
por: Vetter, Marcus, et al.
Publicado: (2017)

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.
por: Saarto, T., et al.
Publicado: (1997)

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990)

Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
por: Xi, Xun, et al.
Publicado: (2022)

Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
por: Guo, Qiusheng, et al.
Publicado: (2023)

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
por: Labrosse, Julie, et al.
Publicado: (2020)

Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
por: McArdle, Colin S, et al.
Publicado: (2010)

The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011)

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.
por: Stål, O., et al.
Publicado: (1994)

Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer
por: Shinohara, Tsuyoshi, et al.
Publicado: (2013)

Retracted: Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: and Mathematical Methods in Medicine, Computational
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r7f28i26691u0d5ofqmoql6cha